Skip to main content
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
33.40
+0.18 (0.54%)
At close: Dec 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2008 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Antibody-cleaving Enzyme Technology Platform
171.32M
Log In
Log In
Log In
Log In
Upgrade
Antibody-cleaving Enzyme Technology Platform Growth
27.76%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2008 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Europe
140.24M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
31.46%
Log In
Log In
Log In
Log In
Upgrade
North America
27.96M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
1.97%
Log In
Log In
Log In
Log In
Upgrade
Sweden
3.12M
Log In
Log In
Log In
Log In
Upgrade
Sweden Growth
-
Log In
Log In
Log In
Log In
Upgrade